New Study Reveals Widespread Drug Resistance Across 14 African Countries
On Jul. 23, 2025, results from a newly published study highlight the growing spread of drug resistance across…
Biotechnology | Diagnostics | HIV | Infectious Disease | Influenza | Polio | Therapeutics | Vaccine
Africa’s Plan to Fill Health Funding Gaps Amidst Declining Coffers
On Apr. 11, 2025, Africa’s top public health institution announced it is planning to tap more funds from…
Agriculture | Artificial Intelligence | Biotechnology | CDC | Cloning | Diagnostics | HIV | Infectious Disease | Nanotechnology | Neurology | NIH | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | USDA | Vaccine | WHO | Women's Health
75% of U.S. scientists who answered Nature poll consider leaving
On Mar. 27, 2025, a Nature survey of more than 1,200 scientists, three-quarters of the total respondents are…
Africa CDC Deployed Experts to Investigate unknown Disease X outbreak in Democratic Republic of Congo
On Dec. 9, 2024, the Africa Centers for Disease Control (CDC) announced that it is working closely with…
Biotechnology | COVID-19 | HIV | Vaccine
mpox confirmed in two more nations
On Dec. 5, 2024, the World Health Organization (WHO) announced that as of December 1, 20 countries have…
Moderna announced MOU to supply up to 110 million doses of Its COVID-19 vaccine to the African Union
On Oct. 26, 2021, Moderna announced a new Memorandum of Understanding (MoU) to make up to 110 million…
Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year
On Oct. 7, 2021, Moderna announced it was building a state-of-the-art mRNA facility in Africa with the goal…
first human case of mpox Reported in the Democratic Republic of Congo
In 1970, the first human case of mpox was reported in the Democratic Republic of the Congo (DRC)…
mpox was first discovered
In 1958, mpox (MPVX) was first discovered when two nonfatal outbreaks of a pox-like disease were reported in…